"Loratadine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
Descriptor ID |
D017336
|
MeSH Number(s) |
D02.455.426.559.847.181.384.340.500 D03.383.621.160.500 D04.615.181.384.340.500
|
Concept/Terms |
Loratadine- Loratadine
- 4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester
|
Below are MeSH descriptors whose meaning is more general than "Loratadine".
Below are MeSH descriptors whose meaning is more specific than "Loratadine".
This graph shows the total number of publications written about "Loratadine" by people in this website by year, and whether "Loratadine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Loratadine" by people in Profiles.
-
A 1-day imported fire ant rush immunotherapy schedule with and without premedication. Ann Allergy Asthma Immunol. 2013 Dec; 111(6):562-6.
-
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2003 Apr; 48(4):535-41.
-
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2003 Mar; 111(3):617-22.
-
Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 1996 Feb; 97(2):588-95.